Chimeric Antigen Receptor T‐Cell Therapy: Potentially Nephrotoxic?
Portuguese National Funding Agency for Science, Research and Technology (RCAAP Project by FCT) · 04.01.2024
DOI: 10.71749/pkj.20 ↗Kurz gefasst
Fachartikel in der Zeitschrift Portuguese National Funding Agency for Science, Research and Technology (RCAAP Project by FCT), erschienen am 04.01.2024. Verfasst von Alferes und 11 weiteren Autor:innen.
Abstract (Originalsprache)
Introduction
Chimeric antigen receptor (CAR) T‑cell therapy is an effective new treatment for hematologic malignancies. In this study, we aimed to characterize the acute kidney injury (AKI) and electrolyte disorders among adults with refractory and relapsed haematological malignancies treated with CAR‑T therapy and explore clinical outcomes.
Methods
A retrospective, observational study was performed. Adult patients who received anti‑CD19 CAR ‑T therapy between January 2019 and July 2022 were screened for inclusion.
Results
Among 41 patients receiving CAR T‑cell therapy, cytokine release syndrome and neurotoxicity rates occurred in 65.9% and 19.5%, respectively. AKI occurred in 6 patients (14.6%): 4 had stage 1 AKI and 2 developed stage 2 AKI, all related to decreased kidney perfusion. Electrolyte abnormalities occurred in 65.9% and most of them were clinically mild.
Conclusion
In this study, the incidence of AKI was low, with a complete resolution in most cases by the end of follow‑up. Electrolyte abnormalities were common among recipients of CAR ‑T, although of low severity.
Schlagwörter
Zitieren
APA
Alferes, Daniela, Coelho, I., Ferreira, H., Chuva, T., Paiva, Ana, Chacim, S. P., Mariz, Mário, J., Costa, M., & José (2024). Chimeric Antigen Receptor T‐Cell Therapy: Potentially Nephrotoxic?. Portuguese National Funding Agency for Science, Research and Technology (RCAAP Project by FCT). https://doi.org/10.71749/pkj.20
Vancouver
Alferes, Daniela, Coelho I, Ferreira H, Chuva T, Paiva, et al. Chimeric Antigen Receptor T‐Cell Therapy: Potentially Nephrotoxic?. Portuguese National Funding Agency for Science, Research and Technology (RCAAP Project by FCT). 2024. doi:10.71749/pkj.20
BibTeX
@article{Alferes2024,
author = {Alferes and Daniela and Coelho, Inês and Ferreira, Hugo and Chuva, Teresa and Paiva and Ana and Chacim, Sergio Pereira and Mariz and Mário, José and Costa, Maximino and José},
title = {Chimeric Antigen Receptor T‐Cell Therapy: Potentially Nephrotoxic?},
journal = {Portuguese National Funding Agency for Science, Research and Technology (RCAAP Project by FCT)},
year = {2024},
doi = {10.71749/pkj.20}
}
EUVIMED